785 related articles for article (PubMed ID: 33688188)
1. Investigating Halloysite Nanotubes as a Potential Platform for Oral Modified Delivery of Different BCS Class Drugs: Characterization, Optimization, and Evaluation of Drug Release Kinetics.
Husain T; Shoaib MH; Ahmed FR; Yousuf RI; Farooqi S; Siddiqui F; Imtiaz MS; Maboos M; Jabeen S
Int J Nanomedicine; 2021; 16():1725-1741. PubMed ID: 33688188
[TBL] [Abstract][Full Text] [Related]
2. Halloysite nanotubes-cellulose ether based biocomposite matrix, a potential sustained release system for BCS class I drug verapamil hydrochloride: Compression characterization, in-vitro release kinetics, and in-vivo mechanistic physiologically based pharmacokinetic modeling studies.
Husain T; Shoaib MH; Ahmed FR; Yousuf RI; Siddiqui F; Saleem MT; Farooqi S; Jabeen S
Int J Biol Macromol; 2023 Nov; 251():126409. PubMed ID: 37598820
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy.
Li W; Liu D; Zhang H; Correia A; Mäkilä E; Salonen J; Hirvonen J; Santos HA
Acta Biomater; 2017 Jan; 48():238-246. PubMed ID: 27815166
[TBL] [Abstract][Full Text] [Related]
4. Fabrication and characterization of polymer-ceramic nanocomposites containing drug loaded modified halloysite nanotubes.
Ghaderi-Ghahfarrokhi M; Haddadi-Asl V; Zargarian SS
J Biomed Mater Res A; 2018 May; 106(5):1276-1287. PubMed ID: 29314595
[TBL] [Abstract][Full Text] [Related]
5. Halloysite nanotubes in analytical sciences and in drug delivery: A review.
Fizir M; Dramou P; Dahiru NS; Ruya W; Huang T; He H
Mikrochim Acta; 2018 Jul; 185(8):389. PubMed ID: 30046919
[TBL] [Abstract][Full Text] [Related]
6. Natural halloysite nanotubes /chitosan based bio-nanocomposite for delivering norfloxacin, an anti-microbial agent in sustained release manner.
Barman M; Mahmood S; Augustine R; Hasan A; Thomas S; Ghosal K
Int J Biol Macromol; 2020 Nov; 162():1849-1861. PubMed ID: 32781129
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy of doxorubicin-encapsulated halloysite nanotubes.
Li K; Zhang Y; Chen M; Hu Y; Jiang W; Zhou L; Li S; Xu M; Zhao Q; Wan R
Int J Nanomedicine; 2018; 13():19-30. PubMed ID: 29296083
[TBL] [Abstract][Full Text] [Related]
8. Augmentin loaded functionalized halloysite nanotubes: A sustainable emerging nanocarriers for biomedical applications.
Verma D; Okhawilai M; Senthilkumar N; Subramani K; Incharoensakdi A; Raja GG; Uyama H
Environ Res; 2024 Feb; 242():117811. PubMed ID: 38043896
[TBL] [Abstract][Full Text] [Related]
9. Gamma-aminobutyric acid loaded halloysite nanotubes and in vitro-in vivo evaluation for brain delivery.
Kırımlıoğlu GY; Yazan Y; Erol K; Çengelli Ünel Ç
Int J Pharm; 2015 Nov; 495(2):816-26. PubMed ID: 26387616
[TBL] [Abstract][Full Text] [Related]
10. pH and near-infrared active; chitosan-coated halloysite nanotubes loaded with curcumin-Au hybrid nanoparticles for cancer drug delivery.
Rao KM; Kumar A; Suneetha M; Han SS
Int J Biol Macromol; 2018 Jun; 112():119-125. PubMed ID: 29378273
[TBL] [Abstract][Full Text] [Related]
11. Halloysite nanotubes for efficient loading, stabilization and controlled release of insulin.
Massaro M; Cavallaro G; Colletti CG; D'Azzo G; Guernelli S; Lazzara G; Pieraccini S; Riela S
J Colloid Interface Sci; 2018 Aug; 524():156-164. PubMed ID: 29649624
[TBL] [Abstract][Full Text] [Related]
12. Halloysite clay nanotubes for life sciences applications: From drug encapsulation to bioscaffold.
Santos AC; Ferreira C; Veiga F; Ribeiro AJ; Panchal A; Lvov Y; Agarwal A
Adv Colloid Interface Sci; 2018 Jul; 257():58-70. PubMed ID: 29887382
[TBL] [Abstract][Full Text] [Related]
13. Nano-composite of poly(L-lactide) and halloysite nanotubes surface-grafted with L-lactide oligomer under microwave irradiation.
Luo BH; Hsu CE; Li JH; Zhao LF; Liu MX; Wang XY; Zhou CR
J Biomed Nanotechnol; 2013 Apr; 9(4):649-58. PubMed ID: 23621025
[TBL] [Abstract][Full Text] [Related]
14. Smart H
Liu F; Bai L; Zhang H; Song H; Hu L; Wu Y; Ba X
ACS Appl Mater Interfaces; 2017 Sep; 9(37):31626-31633. PubMed ID: 28862828
[TBL] [Abstract][Full Text] [Related]
15. Optimization of diclofenac sodium profile from halloysite nanotubules.
Krejčová K; Deasy PB; Rabišková M
Ceska Slov Farm; 2013 Apr; 62(2):71-7. PubMed ID: 23822571
[TBL] [Abstract][Full Text] [Related]
16. The application of halloysite tubule nanoclay in drug delivery.
Lvov YM; DeVilliers MM; Fakhrullin RF
Expert Opin Drug Deliv; 2016 Jul; 13(7):977-86. PubMed ID: 27027933
[TBL] [Abstract][Full Text] [Related]
17. Plasmonic photothermal release of docetaxel by gold nanoparticles incorporated onto halloysite nanotubes with conjugated 2D8-E3 antibodies for selective cancer therapy.
Taheri-Ledari R; Zhang W; Radmanesh M; Cathcart N; Maleki A; Kitaev V
J Nanobiotechnology; 2021 Aug; 19(1):239. PubMed ID: 34380469
[TBL] [Abstract][Full Text] [Related]
18. Cefixime loaded bare and functionalized halloysite nanocarriers and their biomedical applications.
Verma D; Okhawilai M; Subramani K; Chandrasekaran K; Kasemsiri P; Uyama H
Environ Res; 2024 Jul; 252(Pt 2):118927. PubMed ID: 38631467
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Characterization of Carvedilol-Etched Halloysite Nanotubes Composites with Enhanced Drug Solubility and Dissolution Rate.
Maggi L; Urru C; Friuli V; Ferrara C; Conti DM; Bruni G; Capsoni D
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110635
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide releasing halloysite nanotubes for biomedical applications.
Ghalei S; Hopkins S; Douglass M; Garren M; Mondal A; Handa H
J Colloid Interface Sci; 2021 May; 590():277-289. PubMed ID: 33548611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
